These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9020369)

  • 1. Administration of high doses of recombinant human erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial.
    Bourantas K; Economou G; Georgiou J
    Eur J Haematol; 1997 Jan; 58(1):22-5. PubMed ID: 9020369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
    Chaidos A; Makis A; Hatzimichael E; Tsiara S; Gouva M; Tzouvara E; Bourantas KL
    Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.
    Elalfy MS; Adly AA; Ismail EA; Elhenawy YI; Elghamry IR
    Eur J Haematol; 2013 Dec; 91(6):522-33. PubMed ID: 23927461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient.
    Makis AC; Chaliasos N; Hatzimichael EC; Bourantas KL
    Ann Hematol; 2001 Aug; 80(8):492-5. PubMed ID: 11563599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal globin stimulation during a short-term trial of erythropoietin in HbS/beta-thalassemia patients.
    Bourantas KL; Georgiou I; Seferiadis K
    Acta Haematol; 1994; 92(2):79-82. PubMed ID: 7529455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin trial in thalassemia intermedia.
    Nişli G; Kavakli K; Vergin C; Oztop S; Cetingül N
    J Trop Pediatr; 1996 Dec; 42(6):330-4. PubMed ID: 9009557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA; al-Momen A; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F; Warsy AS
    Acta Haematol; 1995; 94(3):128-34. PubMed ID: 7502628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report.
    Lialios G; Makrydimas G; Tsanadis G; Lolis D; Bourantas K
    Minerva Ginecol; 2000; 52(1-2):29-31. PubMed ID: 10851861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of rHuEPO administered to adult patients with thalassemia intermedia.
    Dore F; Gaviano E; Bonfigli S; Pardini S; Pistidda P; Guiso L; Longinotti M
    Ann Hematol; 1994 Oct; 69(4):211-2. PubMed ID: 7948309
    [No Abstract]   [Full Text] [Related]  

  • 10. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Law CB; Ting SM; Li P; Lai KN
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLINICAL APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN BETA-THALASSAEMIA INTERMEDIA.
    Asadov Ch; Alimirzoyeva Z; Hasanova M; Mammadova T; Shirinova A
    Georgian Med News; 2016 Jun; (255):86-92. PubMed ID: 27441542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.
    Mirtsching B; Charu V; Vadhan-Raj S; Colowick AB; Rossi G; Tomita D; McGuire WP
    Oncology (Williston Park); 2002 Oct; 16(10 Suppl 11):31-6. PubMed ID: 12435171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
    J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.
    Galanello R; Barella S; Turco MP; Giagu N; Cao A; Dore F; Liberato NL; Guarnone R; Barosi G
    Blood; 1994 Jan; 83(2):561-5. PubMed ID: 7506955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant erythropoietin in thalassemic patients on dialysis.
    Lai KN; Wong KC; Li PK; Lui SF
    Am J Kidney Dis; 1992 Mar; 19(3):239-45. PubMed ID: 1553968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
    Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
    Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of recombinant human erythropoietin in the treatment of thalassemia.
    Rachmilewitz EA; Aker M
    Ann N Y Acad Sci; 1998 Jun; 850():129-38. PubMed ID: 9668535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassaemia.
    Rachmilewitz EA; Aker M; Perry D; Dover G
    Br J Haematol; 1995 Jun; 90(2):341-5. PubMed ID: 7794754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant erythropoietin trial in children with transfusion-dependent homozygous beta-thalassemia.
    Nisli G; Kavakli K; Aydinok Y; Oztop S; Cetingül N; Basak N
    Acta Haematol; 1997; 98(4):199-203. PubMed ID: 9401497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.